{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:05:41Z","timestamp":1779951941350,"version":"3.53.1"},"reference-count":89,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/13543784.2026.2674645","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:38:26Z","timestamp":1779388706000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["A novel sequential ketamine and D-cycloserine\/lurasidone therapy for bipolar depression with acute suicidal ideation"],"prefix":"10.1080","volume":"35","author":[{"given":"Mina","family":"Takahashi","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham","place":["Huntsville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Shelton","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham","place":["Huntsville, USA"]},{"name":"University of Alabama at Birmingham","place":["Huntsville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.70048"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415617657"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.01.022"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-023-00308-5"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.2009.02084.x"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.03.013"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112136"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.12.019"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.12.034"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7580.2005.00443.x"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-15-06810.2002"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200023"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00127"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105748"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.163"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149753"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30833"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1222939"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/neu.20025"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhi104"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.54"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.12.033"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2886"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01352-4"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01922-1"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00309-0"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02040-8"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12497"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.255"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1636017"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2020.03.002"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4050"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814709116"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6619515"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211036814"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3478"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-07141-3"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.23.1081"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020157"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23m15246"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129702"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.03.001"},{"key":"e_1_3_3_46_1","volume-title":"Seromycin [package insert]","author":"Acme Pharmaceuticals, Inc","year":"2025","unstructured":"Acme Pharmaceuticals, Inc. Seromycin [package insert]. New York (NY): Acme Pharmaceuticals, Inc.; 2025."},{"key":"e_1_3_3_47_1","unstructured":"NeuroRx Inc. Sequential therapy (NRX-100 followed by NRX-101) for the treatment of acute suicidal ideation and behavior in bipolar depression: the STABIL-B study. ClinicalTrials.gov. 2018 [cited 2025 Dec 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02974010"},{"key":"e_1_3_3_48_1","volume-title":"Clinical study protocol NRX101-003: a randomized, double-blind controlled comparison of NRX-101 to lurasidone for adults with bipolar depression and subacute suicidal ideation or behavior. Final version 4.0, 09 November 2023","author":"Nierenberg A","year":"2023","unstructured":"Nierenberg A. Clinical study protocol NRX101-003: a randomized, double-blind controlled comparison of NRX-101 to lurasidone for adults with bipolar depression and subacute suicidal ideation or behavior. Final version 4.0, 09 November 2023. Wilmington (DE):NRx Pharma, Inc.; 2023. IND 129194, Phase 2b"},{"key":"e_1_3_3_49_1","unstructured":"NeuroRx Inc. NRX-101 for bipolar depression with subacute suicidal ideation NCT03395392. ClinicalTrials.gov. Available from: 2024. [cited 2025 Dec 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03395392"},{"key":"e_1_3_3_50_1","unstructured":"NeuroRx Inc. NRX100 vs. Placebo for rapid stabilization of acute suicidal ideation and behavior in bipolar depression (SevereBD). ClinicalTrials.gov. 2024 [cited 2025 Dec 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03396601"},{"key":"e_1_3_3_51_1","unstructured":"NRx Pharmaceuticals. NRx pharmaceuticals (Nasdaq: nRXP) announces promising findings in phase 2b\/3 clinical trial of NRX-101 vs. Lurasidone for treatment of suicidal bipolar depression. PR Newswire. 2024 [cited 2025 Dec 7]. Available from: https:\/\/www.prnewswire.com\/news-releases\/nrx-pharmaceuticals-nasdaqnrxp-announces-promising-findings-in-phase-2b3-clinical-trial-of-nrx-101-vs-lurasidone-for-treatment-of-suicidal-bipolar-depression-302131482.html"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-020-0498-9"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00411218"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs012"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00073-9"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5390-09.2010"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.241"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0365-06.2006"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.12197"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145702003061"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.11.2115"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.3955"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093519"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.3255"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013457.pub2"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160321123221"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000910"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4823-2"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14l09527"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.02.030"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/10915818231176971"},{"key":"e_1_3_3_73_1","unstructured":"NRx Pharmaceuticals. Nrx pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of transcranial magnetic stimulation. 2025 cited 2025 Dec 7]. Available from: https:\/\/ir.nrxpharma.com\/news-releases\/news-release-details\/nrx-pharmaceuticals-discuss-new-nrx-101-pipeline-indication#:~:text=In%20the%20third%20quarter%2C%20the the%20brain%20associated%20with%20depression"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1085"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00302.x"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S366769"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1554337"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.1.131"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1517\/eoph.4.7.1175.21063"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.2006.2.2.187"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S5819"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2004.080028"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160321122703"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2014.966175"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30132824"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114892"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20190048"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/24705470221128017"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X12666140619204251"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57111256"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21073"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2026.2674645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:51:27Z","timestamp":1779951087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2026.2674645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/13543784.2026.2674645"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2026.2674645","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}